Product Wiki · Recalls · EU Safety Gate (RAPEX)

Lait Éclaircissant - Energie - Lightening Milk — recall SR/03597/25

EU Safety Gate (RAPEX) · Germany · 2025-10-24 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/03597/25
Date of alert
2025-10-24
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Pr. Francoise Bedon Paris
Product category
Cosmetics
Product type
Skin lightening milk
Barcode (EAN/GTIN)
3045621624522
Reported risk: The product contains hydroquinone (measured value up to 6.2%), which is prohibited in cosmetic products. Hydroquinone may cause an allergic skin reaction, can cause cancer and causes serious eye damage. Moreover, according to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Retailer
Category of measure
Stop of sales
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10096211

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.